Supplier
Regents of the University of California
Regents of the University of California was paid $315K by Medicaid between Jul 2018 and Nov 2024, across 8 billing codes. Its largest line is J7503, Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg — 60% of everything it billed.
33Billing provider infoREGENTS OF THE UNIVERSITY OF CALIFORNIA
SACRAMENTO, CA 95820
SACRAMENTO, CA 95820
33aNPI1578639308assigned 11/24/2006
33bProvider typePharmacy
28Total paid$315K
24GClaims37,675
24DCodes billed8
24AFirst – last monthJul 2018 – Nov 2024
Compared with peers
Next to other Pharmacy providers in California
Rank by total paid#25 of 179
Median peer was paid$2K
This provider vs. median178×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,861 | $13K | |
| 2019 | 6,077 | $36K | |
| 2020 | 6,380 | $83K | |
| 2021 | 6,396 | $39K | |
| 2022 | 6,457 | $31K | |
| 2023 | 4,567 | $43K | |
| 2024incomplete | 3,937 | $70K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 60% | 2,238 | 1,938 | $188K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 18% | 6,523 | 5,685 | $56K |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 14% | 6,639 | 6,264 | $45K |
| J7518 | Mycophenolic acid, oral, 180 mg | 3.3% | 525 | 480 | $10K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 2.5% | 8,080 | 7,835 | $8K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 1.6% | 11,232 | 9,267 | $5K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 2,304 | 2,077 | $1K |
| 99199 | Unlisted special service, procedure or report | <1% | 134 | 98 | $703.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOLL, JENNIFER (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Oregon Health & Science University | Portland, OR | $70.79M |
| Oregon Health & Science University | Portland, OR | $387.48 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.